Baker Avenue Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70	Closed	-$496	–	470
2023 Q3	$496	Buy	+70	New	+$496	﹤0.01%	1442
2023 Q1	–	Sell	-55	Closed	-$631	–	1613
2022 Q4	$631	Buy	+55	New	+$631	﹤0.01%	1230